These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 133479)

  • 1. Induction of neonatal transplantation tolerance. Do MLC antigens provide the major barrier?
    Brooks CG
    Transplantation; 1976 Apr; 21(4):347-50. PubMed ID: 133479
    [No Abstract]   [Full Text] [Related]  

  • 2. Neonatally induced transplantation tolerance: in vitro evidence supporting a clonal inactivation mechanism.
    Brooks CG
    Eur J Immunol; 1975 Nov; 5(11):741-7. PubMed ID: 150333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal tolerance induction across regions of H-2 complex.
    Streilein JW; Klein J
    J Immunol; 1977 Dec; 119(6):2147-50. PubMed ID: 334985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the role of interleukin-10 in the induction and maintenance of specific transplantation tolerance.
    Holán V; Kosarová M; Lipoldová M
    Folia Biol (Praha); 1994; 40(6):381-94. PubMed ID: 7589697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of anti-donor helper T cells secreting interleukin 4 after neonatal induction of transplantation tolerance.
    Goldman M; Vandervorst P; Lambert P; Doutrelepont JM; Bruyns C; Abramowicz D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):238-9. PubMed ID: 2523130
    [No Abstract]   [Full Text] [Related]  

  • 6. Similarity of cellular recognition structures for histocompatibility antigens and of combining sites of corresponding alloantibodies.
    Ramseier H; Lindenmann J
    Eur J Immunol; 1972 Apr; 2(2):109-14. PubMed ID: 4118769
    [No Abstract]   [Full Text] [Related]  

  • 7. Are histocompatibility antigens in neonatal skin grafts truly tolerogenic?
    Polácková M; Svec M; Viklický V
    Folia Biol (Praha); 1979; 25(2):95-100. PubMed ID: 378720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MLC response of lymphocytes from mice neonatally primed and tolerating skin allografts.
    Cukrová V; Holán V; Rychlíková M
    Folia Biol (Praha); 1981; 27(5):308-17. PubMed ID: 6457758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro reactivity of lymphoid cells from tolerant mice.
    Beverley PC; Brent L; Brooks C; Medawar PB; Simpson E
    Transplant Proc; 1973 Mar; 5(1):679-84. PubMed ID: 4266673
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of histocompatibility antigens on lymphocyte migration in the mouse.
    Zatz MM; Gingrich R; Lance EM
    Immunology; 1972 Nov; 23(5):665-75. PubMed ID: 4539074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depressed lymphoproliferative response in mixed leukocyte reaction after Mis-locus alloimmunization.
    Solana R; Alonso MC; de la Fuente M; Paniagua JA; Rojas R; Peña J
    Rev Esp Fisiol; 1984 Mar; 40(1):1-4. PubMed ID: 6235554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte ecology and immunologic tolerance.
    Levey RH
    Transplant Proc; 1973 Mar; 5(1):893-6. PubMed ID: 4572152
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the capacity of neonatal skin grafts to induce tolerance in adult mice.
    Wachtel SS; Silvers WK
    Adv Biol Skin; 1971; 11():223-31. PubMed ID: 4950053
    [No Abstract]   [Full Text] [Related]  

  • 14. The "Sk" (skin-specific) rejection phenomenon as evidence of the natural role of acquired tolerance.
    Steinmuller D; Lofgreen JS
    Transplant Proc; 1977 Jun; 9(2):1385-91. PubMed ID: 327636
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of neonatal transplantation tolerance and lymphoproliferative disorders in mice: the role of F1 donor cells.
    Jánossy T; Baranyi L; Vizler C; Nyirati I; Végh P
    Transplant Proc; 1995 Feb; 27(1):188-90. PubMed ID: 7878968
    [No Abstract]   [Full Text] [Related]  

  • 16. Neonatal transplantation tolerance results from two types of suppression acting during induction and at the effector phase.
    Streilein JW; Gruchalla RS; Strome P
    Transplant Proc; 1981 Mar; 13(1 Pt 1):578-81. PubMed ID: 7268884
    [No Abstract]   [Full Text] [Related]  

  • 17. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse mixed lymphocyte reactions and cell-mediated lympholysis: genetic control and relevance to antigenic strength.
    Abbasi K; Démant P; Festenstein H; Holmes J; Huber B; Rychiková M
    Transplant Proc; 1973 Dec; 5(4):1329-37. PubMed ID: 4149544
    [No Abstract]   [Full Text] [Related]  

  • 19. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells.
    Bortin MM; Rimm AA; Saltzstein EC; Rodey GE
    Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance to class II major histocompatibility complex molecules is maintained in the presence of endogenous, interleukin-2-producing, tolerogen-specific T lymphocytes.
    Mohler KM; Streilein JW
    J Immunol; 1987 Oct; 139(7):2211-9. PubMed ID: 2958541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.